A clinical chemistry reagent for the determination of myoglobin (MYO) using latex immunoturbidimetry method. This reagent is used for cardiac and muscle injury assessment in clinical diagnostics.
Manufactured by
Beijing Diagreat Biotechnologies Co., Ltd
Beijing, China
Beijing Diagreat Biotechnologies Co., Ltd. (Diagreat), established in 2013, is headquartered in Beijing Economic and Technological Development Zone. Diagreat has a mature research and production platform for core materials upstream of in vitro diagnosis and life science. These include small molecule directional coupling technology, antibody research and production, protein engineering technology, enzyme molecular engineering technology, nucleic acid synthesis and modification, primer-probe synthesis, gene synthesis, and sequencing, etc. Diagreat has a variety of in vitro diagnostic products with domestic registration certificates. The main product lines include the Fluorescent Immunochromatographic - POCT series and the Chemiluminescence series, which supports Therapeutic Drug Monitoring (TDM). Our series have passed CE certification and certifications in Italy, Mexico, Ecuador, etc. These products are currently utilized in more than 60 countries and regions globally. Diagreat has dozens of patented inventions. We successively won the honorary titles of 'National High-tech Enterprise', 'Zhongguancun High-tech Enterprise', 'Beijing 'Specialization, Refinement, Differentiation, Innovation' of Small and Medium-sized Enterprises', 'Beijing Golden Seed Enterprise', 'Yizhuang Deloitte Top 20 growth' and other honorary titles. Diagreat has won the First Prize for Scientific and Technological Progress in Beijing, undertaken one national key scientific and technological research and development project, and has successively completed a number of key scientific and technological research and development projects in Beijing, as well as a number of regional science and technology projects.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Boditech Med Inc.
South Korea · 3 relevant products
Xiamen Micalrun Technology Co.,Ltd
China · 3 relevant products
Shanghai STAC Biotechnology Co., Ltd.
China · 1 relevant product
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 32 relevant matches
Boditech Med Inc. · South Korea
A diagnostic reagent for assessing and diagnosing acute myocardial infarction. It measures myoglobin levels to help guide appropriate treatment decisions in cardiac emergencies.
Xiamen Micalrun Technology Co.,Ltd · China
A chemiluminescence platform diagnostic reagent for detecting myoglobin (MYO). This product is used for rapid and effective diagnosis of myocardial injury, myocardial infarction, myocarditis, and heart failure from multiple perspectives. It demonstrates high sensitivity and specificity, wide linear range, and good reproducibility with results highly consistent with imported comparable products.
Wuhan Life Origin Biotech Joint Stock Co., Ltd. · China
This product is used for quantitative determination of troponin I (cTnI), creatine kinase isoenzyme (CK-MB), and myoglobin (Myo) in human serum, plasma, and whole blood in vitro.
29 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products